Gilead and Tentarix partner on cancer and inflammation therapies

Gilead Sciences has entered into partnerships with Tentarix for the development of new therapies for oncology and inflammatory diseases.

Aug 16, 2023 - 20:00

Gilead and Tentarix partner on cancer and inflammation therapies

Gilead Sciences has entered into partnerships with Tentarix for the development of new therapies for oncology and inflammatory diseases.

Read the original article

Tags:

Previous Article

Leprosy potentially endemic in Central Florida

Patient Death Causes 2seventy Bio’s CD33-Targeted CAR-T Cell Therapy Trial to be...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Gedeptin by GeoVax Labs for Nasopharyngeal Cancer: Like...

Nov 16, 2023

STAT+: Rune Labs, which makes an app to track Parkinson’s symptoms, raises $12 million

STAT+: Rune Labs, which makes an app to track Parkinson...

Jan 12, 2024

STAT+: Option Care takes over Amedisys in ‘perplexing’ $3.6 billion home care deal

STAT+: Option Care takes over Amedisys in ‘perplexing’ ...

May 5, 2023